Document Detail


Uterine perforation as a rare complication of attempted pregnancy termination with misoprostol: a case report.
MedLine Citation:
PMID:  16913556     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Abortion induced by drugs is now a viable alternative to surgically induced abortion, but it can cause severe complications. CASE: Products of conception were found in the peritoneal cavity after administration of misoprostol. CONCLUSION: The administration of misoprostol for pregnancy termination should be performed carefully in women with uterine wall defects.
Authors:
Georgios Lialios; Athanasios Kallitsaris; Jordan Mademtzis; Ioannis E Messinis
Related Documents :
15980646 - Success rate for culture of fetal postmortem tissue is dependent on the method of pregn...
17320086 - Intravaginal gemeprost and second-trimester pregnancy termination in the scarred uterus.
12819986 - Mirtazapine (remergil) for treatment resistant hyperemesis gravidarum: rescue of a twin...
17961566 - Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks.
7195836 - Further evaluation of the split ejaculate for artificial insemination.
1021086 - Fertility test of frozen boar semen.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Journal of reproductive medicine     Volume:  51     ISSN:  0024-7758     ISO Abbreviation:  J Reprod Med     Publication Date:  2006 Jul 
Date Detail:
Created Date:  2006-08-17     Completed Date:  2006-11-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0173343     Medline TA:  J Reprod Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  599-600     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, University of Thessalia, Larissa, Thessalia, Greece. lialiosg@yahoo.gr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortifacient Agents, Nonsteroidal / adverse effects*
Abortion, Induced / adverse effects,  methods*
Adult
Combined Modality Therapy
Dilatation and Curettage / adverse effects*
Female
Humans
Laparoscopy
Misoprostol / adverse effects*
Peritoneal Cavity / pathology
Pregnancy
Uterus / injuries*,  surgery
Chemical
Reg. No./Substance:
0/Abortifacient Agents, Nonsteroidal; 59122-46-2/Misoprostol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Tubal gestation and schistosomiasis: a case report.
Next Document:  The HESI exit exam: Progression benchmark and remediation guide.